Knight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada
Knight Therapeutics MONTREAL, Sept. 15, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US)…
#Canada #benignprostatichyperplasia #detrusormuscle #HealthCanada #Knight #KnightTherapeuticsInc. #lowerurinarytractsymptoms #overactivebladder #pharmacologicaltherapy #urinaryfrequency #urinaryincontinence #urinarytract #urinarytractinfection #urinaryurgency
https://www.europesays.com/canada/210408/